SAAVY
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Jun 2023)
What this means for you
This application is over — abandoned 26 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90513988
- Mark type
- Stylized text
- Filed
- 05 Feb 2021
- Published for opposition
- 29 Mar 2022
- Abandoned
- 26 Jun 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy and gene editing; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy; biotechnological platform technology, namely, biological nanoparticles for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; drug delivery agents consisting of compounds comprised of proteins in the form of capsids and particles that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents, in the form of injectable solutions, intravenous fluids, intracerebral solutions, intrathecal solutions, intracisternal solutions, intraocular solutions, intranasal solutions, intratracheal solutions, intraarterial solutions, intramuscular solutions, and medicinal infusions in that facilitate the delivery of capsids and particles used for delivery of gene therapy
- Class 042 — Scientific and technological services: medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that feature adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy
Owner
- LogicBio Therapeutics, Inc., Lexington, MA, US
- LogicBio Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 03 Aug 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 03 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Jun 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jun 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2022 — SOU EXTENSION 1 GRANTED
- 18 Nov 2022 — SOU EXTENSION 1 FILED
- 18 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 24 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Mar 2022 — PUBLISHED FOR OPPOSITION